Delivery Order SPE2DB24D8002-SPE2DB25FJNRC
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,571.81, is for the delivery of Vraylar 1.5 mg capsules. The award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. This IDC allows the company to provide a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, with a ceiling value of $17,061.88, is for the delivery of the prescription medication Vraylar (1.5 mg capsule, 30 count) to support U.S. Armed Forces medical operations. The award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc.,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,402.93 contract is for the delivery of 1.5 mg VRAYLAR capsules. The order has an ultimate completion date of March 12, 2025 and is not associated with a set-aside program. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, allowing the company...
The Defense Logistics Agency (DLA) awarded a $12,321.87 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4,565,219,647 units of the prescription drug Vraylar 6 mg capsule. This delivery order contract is part of a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which seeks to procure commercial medical equipment,...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,726.07 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract does not have a set-aside designation. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a comprehensive...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,226.57, is a firm-fixed-price delivery order for the supply of VRAYLAR 4.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical products to...
This federal contract award, valued at $4,508.95, was issued by the Defense Logistics Agency (DLA) to prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of August 28, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program,...
This is a delivery order for $2,762.65 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The order is for the pharmaceutical product Vraylar 4.5 mg capsule, with a performance period ending on April 9, 2024. The contract is a firm fixed-price arrangement without any set-aside designation. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the federal government, particularly the...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4565192015 VRAYLAR 1.5 MG CAPSULE 30S. The contract has a ceiling value of $1,894.42 and a period of performance through July 19, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a comprehensive range of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJUCG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,567,730,837 units of the pharmaceutical product VRAYLAR 3 MG CAPSULE 30S. The contract has a firm fixed price of $8,064.57 and a completion date of March 31, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) vehicle,...